Mr Daniel Hassan

Higher Degree by Research Candidate

School of Pharmacy and Biomedical Sciences

College of Health


I am a PhD student in the SAiGENCI T-cell Immunotherapy Laboratory, supervised by Dr. Mara Zeissig. My project involves investigating the role of precursor exhausted T cells (Tpex cells) in anti-tumour immunity. These cells are the major reservoir of anti-tumour T cells in a patient and expand greatly with immune checkpoint blockade therapy, such as those that target the PD-1/PD-L1 pathway. While such therapies have had great success, patient response to therapy is mixed. My work aims to identify new therapeutic targets on Tpex cells that may be incorporated into a combination therapy with immune checkpoint blockades to help improve results within those non-responding patients.

Date Position Institution name
2026 - ongoing PhD Student Adelaide University

Date Type Title Institution Name Country Amount
2026 Scholarship Playford Trust PhD Scholarship The Playford Trust Australia -
2026 Award University Medal University of Adelaide Australia -

Date Institution name Country Title
2026 South Australian immunoGENomics Cancer Institute Australia Doctor of Philosophy (PhD)
2025 - 2025 University of Adelaide Australia Honours in Molecular and Biomedical Science
2022 - 2024 University of Adelaide Australia Bachelor of Science (Advanced)

Year Citation
2026 Wong, Y. Y., Harbison, J., Hassan, D., Gundsambuu, B., Hope, C., Wong, S. W., . . . Barry, S. (2026). Integrative epigenomic and transcriptomic profiling reveals dysregulated T cell regulatory networks in Stage 3 Type 1 diabetes. Research Square. Genome Medicine (Under Review).
DOI

2026-2029 - South Australian Immunogenomics Cancer Institute (SAiGENCI) Scholarship; Research Training Program Scholarship

2026-2029 - South Australian Immunogenomics Cancer Institute (SAiGENCI) Top-Up Scholarship

 


Connect With Me

External Profiles

Other Links